Recent advances in oncolytic virus design

• Autores: Rubén Hernández-Alcoceba
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 13, Nº. 4, 2011, págs. 229-239
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • The cytolytic properties of viruses can be used to treat cancer. Replication of certain viruses is favoured in cancer cells, whereas others can be modified to obtain tumour specificity. This approach has evolved to become a new discipline called virotherapy. In addition, these replication-competent (oncolytic) viruses can be adapted as vectors for cancer gene therapy. The �armed� viruses show a double mechanism of action: direct destruction of cancer cells as a consequence of the lytic viral cycle, in combination with the effect of the therapeutic gene incorporated in the viral genome. Current trends in the field include strategies to increase the oncolytic potency of existing viruses; the evaluation of new candidates; the search for synergistic effects between different viruses and conventional therapies; and a rational approach to take advantage of the interplay between the viruses and the host immune system. This review summarises the most relevant achievements in recent years.